Figure 3. Therapeutic areas covered by public-private partnerships and seed or series A financings. A breakdown of therapeutic areas covered by public-private partnerships (PPPs) in 2013 (I.1) and seed or series A financings (II.1). PPPs by business area (I.2 (2012) and I.3 (2011)) and financings by business area (II.2 (2012) and II.3 (2011)) from the previous two years are provided for comparison. For (I), percentages are out of the total number of PPPs worldwide; bracketed values are actual numbers. For (II), percentages are out of total financing events across all therapeutic areas; bracketed values are the actual number of companies that received financing for a given therapeutic area. Data include double counting as many partnerships and companies are tied to more than one business and/or disease area.